Gilead Sciences, Inc.
A biopharmaceutical company making medicines for HIV, liver disease, and cancer, Gilead's products include HIV treatments like Biktarvy and Descovy, liver therapies Epclusa and Livdelzi, and CAR T-cell cancer therapies Yescarta and Tecartus. Founded in 1987 in Foster City, California, it was originally named Oligogen before being renamed after the "Balm of Gilead," an ancient healing resin mentioned in the Bible—a nod its founder picked up from a play he read in medical school.
Granted 28.8K · Sold 35.0K
Granted 9.3K · Sold 12.0K
Granted 34.4K · Sold 37.0K
Granted 1.1K
Granted 2.7K
Granted 1.1K
Granted 1.1K
Granted 19.1K · Sold 18.0K
Granted 6.1K · Sold 5.0K
Granted 1.1K
Granted 1.8K
Granted 1.1K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| O'Day Daniel PatrickChairman & CEO, Director · 10 transactions | -2.5% | 626.3K | 28.8K | — | 35.0K |
| Dickinson Andrew DChief Financial Officer · 8 transactions | -4% | 171.6K | 9.3K | — | 12.0K |
| Mercier JohannaChief Comm & Corp Aff Officer · 14 transactions | -5.1% | 124.7K | 34.4K | — | 37.0K |
| Barton Jacqueline KDirector · 1 transaction | +4.4% | 27.2K | 1.1K | — | — |
| Berger DietmarChief Medical Officer · 4 transactions | +8.9% | 19.5K | 2.7K | — | — |
| Manwani HarishDirector · 2 transactions | +6.5% | 15.0K | 1.1K | — | — |
| Rodriguez JavierDirector · 1 transaction | +9.4% | 13.4K | 1.1K | — | — |
| Welters AnthonyDirector · 7 transactions | +9.8% | 12.9K | 19.1K | — | 18.0K |
| Bluestone JeffreyDirector · 11 transactions | +12.8% | 10.1K | 6.1K | — | 5.0K |
| Horning SandraDirector · 1 transaction | +22.3% | 6.3K | 1.1K | — | — |
| Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp · 4 transactions | +27.8% | 5.6K | 1.8K | — | — |
| Love Ted WDirector · 1 transaction | +26.4% | 5.5K | 1.1K | — | — |
Select a row to see that insider’s individual transactions.
Net open-market activity over the last 6 months: -107.0K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.